VERTEX PHARMACEUTICALS INC / MA Income Taxes Paid
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Income Taxes Paid of $1.24 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2016-08-01
- VERTEX PHARMACEUTICALS INC / MA income taxes paid for the quarter ending 2016-06-30 was $656.00K, a 31.81% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA income taxes paid for the quarter ending 2016-03-31 was $581.00K, a 868.33% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA income taxes paid for the quarter ending 2015-09-30 was $239.00K.
- VERTEX PHARMACEUTICALS INC / MA income taxes paid for the quarter ending 2015-06-30 was $962.00K, a 46.20% increase year-over-year.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month |
|---|---|---|---|
| 2016-06-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $1.24M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $581.00K 10-Q · filed 2016-05-03 | ||
| 2015-09-30 | $239.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $1.20M derived: sum of 2 quarters · filed 2016-08-01 | $1.26M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $962.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $1.02M 10-Q · filed 2016-08-01 | |
| 2015-03-31 | $60.00K 10-Q · filed 2016-05-03 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $658.00K derived: sum of 2 quarters · filed 2015-10-30 | $798.00K 10-Q · filed 2015-10-30 |
| 2014-06-30 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $798.00K 10-Q · filed 2015-08-04 | |
| 2014-03-31 | $140.00K 10-Q · filed 2015-05-04 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.54M derived: sum of 2 quarters · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 |
| 2013-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | |
| 2013-03-31 | $1.54M 10-Q · filed 2014-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |